单侧视网膜母细胞瘤:儿童治疗方案的疗效审计

IF 6.5 1区 医学 Q1 ONCOLOGY International Journal of Radiation Oncology Biology Physics Pub Date : 2025-03-01 Epub Date: 2025-02-03 DOI:10.1016/j.ijrobp.2024.11.035
N. Khanna , Y. Rathod , J. Manjali , B. Parambil , G. Chinnaswamy , M. Prasad , R. Gollamudi , V. Patil , A. Baheti , K. Gala , S. Shah , P. Panjwani , M. Ramadwar , N. Shetye , S. Qureshi , S. Laskar
{"title":"单侧视网膜母细胞瘤:儿童治疗方案的疗效审计","authors":"N. Khanna ,&nbsp;Y. Rathod ,&nbsp;J. Manjali ,&nbsp;B. Parambil ,&nbsp;G. Chinnaswamy ,&nbsp;M. Prasad ,&nbsp;R. Gollamudi ,&nbsp;V. Patil ,&nbsp;A. Baheti ,&nbsp;K. Gala ,&nbsp;S. Shah ,&nbsp;P. Panjwani ,&nbsp;M. Ramadwar ,&nbsp;N. Shetye ,&nbsp;S. Qureshi ,&nbsp;S. Laskar","doi":"10.1016/j.ijrobp.2024.11.035","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>To evaluate treatment outcome of children diagnosed with unilateral retinoblastoma.</div></div><div><h3>Methods</h3><div>Retrospective study of children diagnosed with unilateral retinoblastoma registered at our institute from January 2013 to December 2018 and completed the curative treatment protocol.</div></div><div><h3>Results</h3><div>For the 98 cases analyzed the median age was 24 months. At the time of presentation, 72 had intraocular and 26 had orbital. On imaging extra-scleral spread was observed in 16 patients whereas 18 patients had optic nerve (ON) involvement, 11 patients had both extra-scleral invasion and ON involvement. Majority we ICRB group E (71), and group D=21, group C= 2, group B=4. Majority were IRSS Stage 1(stage0=14, stage1=52, stage2=10, stage3a=21 and stage3b=1). High-risk features on surgical specimen histopathology were ON margin positivity in 6, ON involvement in 21, extra-scleral spread in 3, choroidal invasion in 38 and iris involvement in 10 patients.</div><div>Eneucleation was offered to 78 (Primary=52, secondary=26). Chemotherapy was offered to 68 (chemoreduction=17, adjuvant chemotherapy=51). Intra-arterial chemotherapy was offered to 27 patients as a primary treatment or in conjugation with focal therapy (n=11). Definitive radiotherapy was offered to only 2 patients and 22 patients received adjuvant radiotherapy.</div><div>At a median follow-up of 62 months, 2 patients had local relapse, which was salvaged by focal therapy in one and enucleation in the other. Ten patients who had leptomeningeal relapse had died. The 5-year local control (LC) is 97.6%, event-free survival (EFS) is 88% and overall survival (OS) is 89.5%. Globe was salvaged in only 16 cases. On univariate analysis, orbital disease, extra-scleral spread, ON involvement (imaging), and ON margin positivity, higher ICRB Group and IRSS stage had poor impact on OS.</div></div><div><h3>Conclusion</h3><div>Retinoblastoma is curable with optimal globe salvage rates if detected early. Orbital disease, high risk features on surgical specimen histopathology and leptomeningeal relapse are associated with inferior outcomes.</div></div>","PeriodicalId":14215,"journal":{"name":"International Journal of Radiation Oncology Biology Physics","volume":"121 3","pages":"Page e9"},"PeriodicalIF":6.5000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Unilateral Retinoblastoma: Audit of Outcomes of Children treated with Curative Treatment Protocol\",\"authors\":\"N. Khanna ,&nbsp;Y. Rathod ,&nbsp;J. Manjali ,&nbsp;B. Parambil ,&nbsp;G. Chinnaswamy ,&nbsp;M. Prasad ,&nbsp;R. Gollamudi ,&nbsp;V. Patil ,&nbsp;A. Baheti ,&nbsp;K. Gala ,&nbsp;S. Shah ,&nbsp;P. Panjwani ,&nbsp;M. Ramadwar ,&nbsp;N. Shetye ,&nbsp;S. Qureshi ,&nbsp;S. Laskar\",\"doi\":\"10.1016/j.ijrobp.2024.11.035\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><div>To evaluate treatment outcome of children diagnosed with unilateral retinoblastoma.</div></div><div><h3>Methods</h3><div>Retrospective study of children diagnosed with unilateral retinoblastoma registered at our institute from January 2013 to December 2018 and completed the curative treatment protocol.</div></div><div><h3>Results</h3><div>For the 98 cases analyzed the median age was 24 months. At the time of presentation, 72 had intraocular and 26 had orbital. On imaging extra-scleral spread was observed in 16 patients whereas 18 patients had optic nerve (ON) involvement, 11 patients had both extra-scleral invasion and ON involvement. Majority we ICRB group E (71), and group D=21, group C= 2, group B=4. Majority were IRSS Stage 1(stage0=14, stage1=52, stage2=10, stage3a=21 and stage3b=1). High-risk features on surgical specimen histopathology were ON margin positivity in 6, ON involvement in 21, extra-scleral spread in 3, choroidal invasion in 38 and iris involvement in 10 patients.</div><div>Eneucleation was offered to 78 (Primary=52, secondary=26). Chemotherapy was offered to 68 (chemoreduction=17, adjuvant chemotherapy=51). Intra-arterial chemotherapy was offered to 27 patients as a primary treatment or in conjugation with focal therapy (n=11). Definitive radiotherapy was offered to only 2 patients and 22 patients received adjuvant radiotherapy.</div><div>At a median follow-up of 62 months, 2 patients had local relapse, which was salvaged by focal therapy in one and enucleation in the other. Ten patients who had leptomeningeal relapse had died. The 5-year local control (LC) is 97.6%, event-free survival (EFS) is 88% and overall survival (OS) is 89.5%. Globe was salvaged in only 16 cases. On univariate analysis, orbital disease, extra-scleral spread, ON involvement (imaging), and ON margin positivity, higher ICRB Group and IRSS stage had poor impact on OS.</div></div><div><h3>Conclusion</h3><div>Retinoblastoma is curable with optimal globe salvage rates if detected early. Orbital disease, high risk features on surgical specimen histopathology and leptomeningeal relapse are associated with inferior outcomes.</div></div>\",\"PeriodicalId\":14215,\"journal\":{\"name\":\"International Journal of Radiation Oncology Biology Physics\",\"volume\":\"121 3\",\"pages\":\"Page e9\"},\"PeriodicalIF\":6.5000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Radiation Oncology Biology Physics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0360301624036095\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/2/3 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Radiation Oncology Biology Physics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0360301624036095","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/3 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的评价儿童单侧视网膜母细胞瘤的治疗效果。方法回顾性研究2013年1月至2018年12月在我院登记的单侧视网膜母细胞瘤患儿,并完成根治性治疗方案。结果98例患者中位年龄为24个月。出现病例时,72例为眼内病变,26例为眼眶病变。影像学上观察到16例患者巩膜外扩散,18例患者有视神经受累,11例患者同时有巩膜外侵犯和视神经受累。多数采用ICRB, E组71例,D组21例,C组2例,B组4例。多数为IRSS 1期(stage0=14, stage1=52, stage2=10, stage3a=21, stage3b=1)。手术标本组织病理学的高危特征为:on边缘阳性6例,on受累21例,巩膜外扩散3例,脉络膜侵犯38例,虹膜受累10例。78例(初级52例,二级26例)行眼球摘除。化疗68例(减量化疗17例,辅助化疗51例)。27例患者接受了动脉内化疗,作为主要治疗或结合局灶治疗(n=11)。最终放疗仅2例,辅助放疗22例。在62个月的中位随访中,2例患者局部复发,其中1例通过局灶治疗,另1例进行去核治疗。10例脑膜轻脑膜复发患者死亡。5年局部控制率(LC)为97.6%,无事件生存率(EFS)为88%,总生存率(OS)为89.5%。Globe只有16个案例被打捞出来。在单因素分析中,眼眶疾病、巩膜外扩散、On受累(成像)和On边缘阳性、较高的ICRB组和IRSS分期对OS影响较小。结论早期发现视网膜母细胞瘤是可治愈的,其全球保存率最高。眼窝疾病、手术标本组织病理学上的高风险特征和脑膜轻脑膜复发与预后较差有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Unilateral Retinoblastoma: Audit of Outcomes of Children treated with Curative Treatment Protocol

Objectives

To evaluate treatment outcome of children diagnosed with unilateral retinoblastoma.

Methods

Retrospective study of children diagnosed with unilateral retinoblastoma registered at our institute from January 2013 to December 2018 and completed the curative treatment protocol.

Results

For the 98 cases analyzed the median age was 24 months. At the time of presentation, 72 had intraocular and 26 had orbital. On imaging extra-scleral spread was observed in 16 patients whereas 18 patients had optic nerve (ON) involvement, 11 patients had both extra-scleral invasion and ON involvement. Majority we ICRB group E (71), and group D=21, group C= 2, group B=4. Majority were IRSS Stage 1(stage0=14, stage1=52, stage2=10, stage3a=21 and stage3b=1). High-risk features on surgical specimen histopathology were ON margin positivity in 6, ON involvement in 21, extra-scleral spread in 3, choroidal invasion in 38 and iris involvement in 10 patients.
Eneucleation was offered to 78 (Primary=52, secondary=26). Chemotherapy was offered to 68 (chemoreduction=17, adjuvant chemotherapy=51). Intra-arterial chemotherapy was offered to 27 patients as a primary treatment or in conjugation with focal therapy (n=11). Definitive radiotherapy was offered to only 2 patients and 22 patients received adjuvant radiotherapy.
At a median follow-up of 62 months, 2 patients had local relapse, which was salvaged by focal therapy in one and enucleation in the other. Ten patients who had leptomeningeal relapse had died. The 5-year local control (LC) is 97.6%, event-free survival (EFS) is 88% and overall survival (OS) is 89.5%. Globe was salvaged in only 16 cases. On univariate analysis, orbital disease, extra-scleral spread, ON involvement (imaging), and ON margin positivity, higher ICRB Group and IRSS stage had poor impact on OS.

Conclusion

Retinoblastoma is curable with optimal globe salvage rates if detected early. Orbital disease, high risk features on surgical specimen histopathology and leptomeningeal relapse are associated with inferior outcomes.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
11.00
自引率
7.10%
发文量
2538
审稿时长
6.6 weeks
期刊介绍: International Journal of Radiation Oncology • Biology • Physics (IJROBP), known in the field as the Red Journal, publishes original laboratory and clinical investigations related to radiation oncology, radiation biology, medical physics, and both education and health policy as it relates to the field. This journal has a particular interest in original contributions of the following types: prospective clinical trials, outcomes research, and large database interrogation. In addition, it seeks reports of high-impact innovations in single or combined modality treatment, tumor sensitization, normal tissue protection (including both precision avoidance and pharmacologic means), brachytherapy, particle irradiation, and cancer imaging. Technical advances related to dosimetry and conformal radiation treatment planning are of interest, as are basic science studies investigating tumor physiology and the molecular biology underlying cancer and normal tissue radiation response.
期刊最新文献
Ureter Tolerance in Patients Treated with Stereotactic Body Radiation Therapy on Abdominopelvic Lymph Nodes: Analysis on Dose-related Late Effects Improving Stereotactic Body Radiation Therapy by Rewiring Immunosuppressive Neutrophils in Murine Pancreatic Ductal Adenocarcinoma The Contribution of Cirrhosis Progression in Liver Dysfunction After Stereotactic Body Radiation Therapy Utility-Based Dose Selection for Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma Preoperative Versus Postoperative Fractionated Stereotactic Radiation Therapy: A Single-Institution Analysis of 534 Resected Metastases
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1